DD01 / Shenzhen Salubris, D&D Pharmatech  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DD01 / D&D Pharmatech
NCT06410924: A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH

Recruiting
2
68
US
DD01, Placebo
Neuraly, Inc.
NAFLD, NASH
03/25
06/26

Download Options